Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$1.93 - $2.7 $11,508 - $16,100
5,963 New
5,963 $15,000
Q3 2023

Nov 14, 2023

BUY
$1.68 - $2.47 $15,247 - $22,417
9,076 Added 85.82%
19,652 $39,000
Q2 2023

Aug 14, 2023

SELL
$1.67 - $2.04 $67,563 - $82,532
-40,457 Reduced 79.28%
10,576 $20,000
Q1 2023

May 15, 2023

SELL
$1.87 - $2.6 $1,325 - $1,843
-709 Reduced 1.37%
51,033 $99,000
Q4 2022

Feb 14, 2023

SELL
$2.49 - $3.5 $48,457 - $68,113
-19,461 Reduced 27.33%
51,742 $131,000
Q3 2022

Nov 14, 2022

SELL
$2.82 - $3.58 $455,765 - $578,596
-161,619 Reduced 69.42%
71,203 $201,000
Q2 2022

Aug 15, 2022

BUY
$2.59 - $3.92 $564,676 - $854,646
218,022 Added 1473.12%
232,822 $656,000
Q1 2022

May 16, 2022

SELL
$3.0 - $4.25 $45,300 - $64,175
-15,100 Reduced 50.5%
14,800 $58,000
Q4 2021

Feb 14, 2022

BUY
$3.85 - $6.71 $55,582 - $96,872
14,437 Added 93.36%
29,900 $117,000
Q3 2021

Nov 15, 2021

BUY
$5.6 - $8.58 $86,592 - $132,672
15,463 New
15,463 $87,000
Q2 2021

Aug 16, 2021

SELL
$7.16 - $9.41 $316,400 - $415,827
-44,190 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$7.52 - $15.55 $130,750 - $270,367
17,387 Added 64.87%
44,190 $418,000
Q4 2020

Feb 16, 2021

BUY
$5.0 - $8.85 $134,015 - $237,206
26,803 New
26,803 $186,000
Q3 2020

Nov 16, 2020

SELL
$4.96 - $7.08 $93,248 - $133,104
-18,800 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$4.84 - $8.02 $90,992 - $150,776
18,800 New
18,800 $113,000
Q1 2020

May 15, 2020

SELL
$4.52 - $8.55 $167,072 - $316,033
-36,963 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$6.14 - $9.3 $85,960 - $130,200
14,000 Added 60.97%
36,963 $284,000
Q3 2019

Nov 14, 2019

BUY
$9.05 - $16.02 $207,815 - $367,867
22,963 New
22,963 $208,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $718M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.